Connection

Robert Harrington to Serine Endopeptidases

Back to Details
This is a "connection" page, showing publications Robert Harrington has written about Serine Endopeptidases.
Robert Harrington
Connection Strength
0.029
Serine Endopeptidases
  1. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. Am Heart J. 2014 Nov; 168(5):682-9.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.